Signs of Success
Dr. Catalona is presenting the case for early detection of prostate cancer at medical conferences across the United States. QUEST is including information from his presentation in this issue and in upcoming issues.
QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Dr. Catalona is presenting the case for early detection of prostate cancer at medical conferences across the United States. QUEST is including information from his presentation in this issue and in upcoming issues.
No way to know for certain that any tumor is insignificant Some academic centers are moving toward not immediately treating prostate cancer patients who have favorable tumor features (i.e., low Gleason grade and low volume of cancer in biopsy specimens),…
(Dr. Catalona received the 2005 Huggins Award from the Society of Urologic Oncology and gave the Award Lecture on The PSA Dilemma in the Overdiagnosis and Underdiagnosis of Prostate Cancer. This article in QUEST is a summary of that lecture…
A Univeral Approach My prior article in QUEST, Winter 2005, described a “universal” approach to achieving a high likelihood of long-term remission and a return to a positive life for a wide range of prostate cancer patients who have low-risk…
To facilitate prostate cancer gene mapping and identification, the ICPCG was established in 2002 Dr. Catalona will be a co-investigator for a prostate cancer susceptibility study sponsored by ICPCG, the International Consortium for Prostate Cancer Genetics. (William Isaacs, PhD, Johns…
Dr. Catalona has built upon his findings to discover various components of PSA One of the most serious dilemmas in diagnosing prostate cancer is that the PSA test, recognized first by Dr. Catalona as an invaluable tool for early detection…
Researchers build upon each other’s findings The possibility that some prostate cancers might be caused by a virus has received media attention in the last few months. If research shows that a virus causes some prostate cancers, then developing new…
Age-Specific Risk of Prostate Cancer: Intro: A man’s risk of developing prostate cancer increases if his baseline PSA is above the median for his age group. Many physicians consider a PSA level of 2.5 or 4.0 ng/ml a threshold for…
"*" indicates required fields